Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (971-980 of 1,298) with videos related to

Pageof 130
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2021
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceFabienne Lamballe, Fahmida Ahmad, Yaron Vinik, et al.
Cancer Cell|May 30, 2009
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastasesShuying Liu, Makiko Umezu-Goto, Mandi Murph, et al.
Gynecologic Oncology|October 19, 2019
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG studyShannon N Westin, Michael W Sill, Robert L Coleman, et al.
Cancers|May 1, 2020
Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma TumorsXiaowen Wang, Matias A Bustos, Xiaoqing Zhang, et al.
Genome Research|April 16, 2017
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancersYumeng Wang, Xiaoyan Xu, Shuangxing Yu, et al.
The New Phytologist|August 16, 2024
From tree to plot: investigating stem CO<sub>2</sub> efflux and its drivers along a logging gradient in Sabah, Malaysian BorneoMaria B Mills, Sabine Both, Palasiah Jotan, et al.
Scientific Reports|November 19, 2023
Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancerTurcin Saridogan, Argun Akcakanat, Ming Zhao, et al.
Cell Reports|May 11, 2016
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian CancerPradeep Chaluvally-Raghavan, Kang Jin Jeong, Sunila Pradeep, et al.
Cancer & Metabolism|June 29, 2016
Metabolic clusters of breast cancer in relation to gene- and protein expression subtypesTonje H Haukaas, Leslie R Euceda, Guro F Giskeødegård, et al.
Science Translational Medicine|May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacyJiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Pageof 130

Showing results (971-980 of 1,298) with videos related to

Sort By:
Pageof 130
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2021
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceFabienne Lamballe, Fahmida Ahmad, Yaron Vinik, et al.
Cancer Cell|May 30, 2009
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastasesShuying Liu, Makiko Umezu-Goto, Mandi Murph, et al.
Gynecologic Oncology|October 19, 2019
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG studyShannon N Westin, Michael W Sill, Robert L Coleman, et al.
Cancers|May 1, 2020
Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma TumorsXiaowen Wang, Matias A Bustos, Xiaoqing Zhang, et al.
Genome Research|April 16, 2017
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancersYumeng Wang, Xiaoyan Xu, Shuangxing Yu, et al.
The New Phytologist|August 16, 2024
From tree to plot: investigating stem CO<sub>2</sub> efflux and its drivers along a logging gradient in Sabah, Malaysian BorneoMaria B Mills, Sabine Both, Palasiah Jotan, et al.
Scientific Reports|November 19, 2023
Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancerTurcin Saridogan, Argun Akcakanat, Ming Zhao, et al.
Cell Reports|May 11, 2016
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian CancerPradeep Chaluvally-Raghavan, Kang Jin Jeong, Sunila Pradeep, et al.
Cancer & Metabolism|June 29, 2016
Metabolic clusters of breast cancer in relation to gene- and protein expression subtypesTonje H Haukaas, Leslie R Euceda, Guro F Giskeødegård, et al.
Science Translational Medicine|May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacyJiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Pageof 130